当前位置:首页 - 行情中心 - 润达医疗(603108) - 财务分析 - 现金流量表

润达医疗

(603108)

  

流通市值:93.93亿  总市值:93.93亿
流通股本:6.04亿   总股本:6.04亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,241,287,710.634,137,668,742.082,071,584,671.469,654,275,178.3
  收到的税费返还8,813,577.046,211,441.022,248,659.1310,550,903.16
  收到其他与经营活动有关的现金87,228,428.7455,853,491.1829,209,454.27145,981,495.57
  经营活动现金流入小计6,337,329,716.414,199,733,674.282,103,042,784.869,810,807,577.03
  购买商品、接受劳务支付的现金4,534,865,275.993,112,027,242.631,486,492,715.427,114,772,539.65
  支付给职工以及为职工支付的现金542,047,242.01380,185,425.24206,955,724.05741,452,530.42
  支付的各项税费281,943,483.62205,064,270.9105,761,067.33559,121,620.05
  支付其他与经营活动有关的现金539,529,562.86348,660,093.21187,163,736.16748,513,507.2
  经营活动现金流出小计5,898,385,564.484,045,937,031.981,986,373,242.969,163,860,197.32
  经营活动产生的现金流量净额438,944,151.93153,796,642.3116,669,541.9646,947,379.71
二、投资活动产生的现金流量:
  收回投资收到的现金292,390,000154,640,00043,800,000374,855,632.92
  取得投资收益收到的现金54,214,972.5443,300,161.8117,506,367.3825,925,043.5
  处置固定资产、无形资产和其他长期资产收回的现金净额11,636,630.156,655,797.082,874,298.637,963,826.48
  收到的其他与投资活动有关的现金1,500,5501,500,5501,500,55010,515,500
  投资活动现金流入小计359,742,152.69206,096,508.8965,681,216.01419,260,002.9
  购建固定资产、无形资产和其他长期资产支付的现金134,130,639.3456,690,397.7820,756,877.05229,163,441.82
  投资支付的现金368,103,353.15136,408,742.8658,922,200572,932,001
  取得子公司及其他营业单位支付的现金---184,499.9
  支付其他与投资活动有关的现金430,410.63294,551.7358,152.0677,646,206.95
  投资活动现金流出小计502,664,403.12193,393,692.3779,737,229.11879,926,149.67
  投资活动产生的现金流量净额-142,922,250.4312,702,816.52-14,056,013.1-460,666,146.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金154,285.71154,285.71-28,000,000
  其中:子公司吸收少数股东投资收到的现金154,285.71154,285.71--
  取得借款收到的现金5,504,120,782.523,821,142,957.21,511,489,033.29,190,935,521.63
  收到其他与筹资活动有关的现金362,930,000229,680,000137,100,000813,006,201.92
  筹资活动现金流入小计5,867,205,068.234,050,977,242.911,648,589,033.210,031,941,723.55
  偿还债务支付的现金5,695,076,556.674,040,624,403.291,746,904,591.758,818,652,152.77
  分配股利、利润或偿付利息支付的现金326,355,295.33194,782,348.1592,063,788.95419,149,507.71
  其中:子公司支付给少数股东的股利、利润106,180,00071,875,50034,420,00081,805,690
  支付其他与筹资活动有关的现金338,469,552.17218,129,404.49118,883,619.92701,841,149.94
  筹资活动现金流出小计6,359,901,404.174,453,536,155.931,957,852,000.629,939,642,810.42
  筹资活动产生的现金流量净额-492,696,335.94-402,558,913.02-309,262,967.4292,298,913.13
四、汇率变动对现金及现金等价物的影响226,848.13,570,941.43-221,319.15-2,856,562.25
五、现金及现金等价物净增加额-196,447,586.34-232,488,512.77-206,870,757.77275,723,583.82
  加:期初现金及现金等价物余额889,011,285.11889,011,285.11889,065,285.11613,287,701.29
  期末现金及现金等价物余额692,563,698.77656,522,772.34682,194,527.34889,011,285.11
补充资料:
  净利润--99,482,170.05-189,458,021.05
  资产减值准备-45,795.63-36,170,132.75
  固定资产和投资性房地产折旧-142,302,639.19-316,869,272.16
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-142,302,639.19-316,869,272.16
  无形资产摊销-10,244,900.18-21,140,270.09
  长期待摊费用摊销-13,938,170.7-27,756,306.35
  处置固定资产、无形资产和其他长期资产的损失-958,792.77--11,463,482.16
  固定资产报废损失-240,583.09-4,978,742.49
  财务费用-138,203,412.23-318,059,213.29
  投资损失--47,447,216.74--109,820,881.18
  递延所得税--17,603,552.94--29,569,256.15
  其中:递延所得税资产减少--16,683,168.13--21,792,264.61
    递延所得税负债增加--920,384.81--7,776,991.54
  存货的减少--259,001,591.83--72,592,557.32
  经营性应收项目的减少--178,485,255.71--115,067,333.81
  经营性应付项目的增加-348,666,438.55--66,980,258.91
  现金的期末余额-656,522,772.34-889,011,285.11
  减:现金的期初余额-889,011,285.11-613,287,701.29
  现金及现金等价物的净增加额--232,488,512.77-275,723,583.82
公告日期2025-10-302025-08-272025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑